Glucotrack announces early accuracy data for its implantable continuous glucose monitor

Rutherford, nj, jan. 02, 2024 (globe newswire) -- glucotrack, inc. (nasdaq: gctk) (“glucotrack” or the “company”), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, provides, updates on initial and long-term preclinical testing for the implantable continuous blood glucose monitor™ (cbgm).
GCTK Ratings Summary
GCTK Quant Ranking